Literature DB >> 26002781

A review of follow-up outcomes after elective endovascular repair of degenerative thoracic aortic aneurysms.

Arnoud V Kamman1, Frederik H W Jonker2, Foeke J H Nauta3, Santi Trimarchi4, Frans L Moll5, Joost A van Herwaarden5.   

Abstract

Long-term outcomes of elective thoracic endovascular aortic repair (TEVAR) for degenerative thoracic aortic aneurysms (TAA) are not well defined. A review of the literature on the follow-up outcomes of elective TEVAR for degenerative TAA resulted in 22 relevant articles. Two- and five-year freedom from aneurysm-related death varied between 93.0% and 100.0%, and 82.4% to 92.7%, respectively. Two-year and five-year all-cause survival ranged between 68.0% and 97.2% and 47.0% to 78.0%, respectively. Follow-up ranged between 17.3 and 66.0 months. Most common endograft-related complication was endoleak, with reported rate between 1.4% and 14.8% during six months up to five years of follow-up. Endovascular reinterventions were reported in 0.0-32.3%, secondary open surgery was needed in 0.0% to 4.7% during follow-up. Aneurysm-related survival rates after elective TEVAR for degenerative TAA are acceptable. However, reported incidences of endograft-related complications vary considerably in the literature, but the majority can be managed with conservative treatment or additional endovascular procedures.
© The Author(s) 2015.

Entities:  

Keywords:  Endovascular procedures/stents; aneurysm; outcomes; thoracic

Mesh:

Year:  2015        PMID: 26002781     DOI: 10.1177/1708538115588648

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  1 in total

1.  1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections.

Authors:  Chang Shu; Hao He; Weiguo Fu; Wei Guo; Ming Li; Erping Xi; Shuguang Guo; Xueming Chen; Zhanxiang Xiao; Shiqiang Yu; Jianhua Huang; Xiangchen Dai; Zhiwei Wang; Wei Li; Qingshan Zheng; Quanming Li; Lunchang Wang; Xin Li; Junwei Wang; Feng Gu
Journal:  Front Cardiovasc Med       Date:  2022-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.